David Bridge

VP, Quality Assurance & Process Development at Celcuity

David has over 30 years of experience as a quality assurance leader, including quality oversight responsibilities for laboratory, manufacturing, and clinical functions. Prior to joining Celcuity, David was Director of Quality Assurance at the Duke University Clinical Research Institute, one of the world’s largest academic clinical research organizations. He had previously served as Senior Director, Quality Assurance for Chimerix, a biopharmaceutical company developing antiviral therapies, and Clinical Quality Assurance Leader at EMD Pharmaceuticals, the US affiliate for Merck KGaA.

Location

Durham, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Celcuity

Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated companion diagnostic (CDx) and therapeutic (Rx) strategy that leverages the CELsignia CDx platform.


Industries

Employees

11-50

Links